Department of Anesthesiology, The Affiliated Hospital of Jiangnan University, Wuxi, 214122, China.
Department of General Surgery, Xishan People's Hospital of Wuxi City, Wuxi, 214105, China.
World J Surg Oncol. 2023 Jan 30;21(1):26. doi: 10.1186/s12957-023-02909-x.
Although laparoscopic pancreaticoduodenectomy (LPD) has been accepted worldwide for treating pancreatic ductal adenocarcinoma (PDA), it is a very technical and challenging procedure. Also, it is unclear whether LPD is superior to open pancreaticoduodenectomy (OPD). This study summarized the experience and efficacy of LPD for treating PDA in our medical center.
This retrospective cohort study included patients with PDA admitted at the Affiliated Hospital of Jiangnan University from October 2019 and January 2021. Patients received either LPD or OPD. Clinical outcomes (operation time, duration of anesthesia, intraoperative hemorrhage), postoperative complications, and short-term outcomes were compared. Cox proportional hazard model and Kaplan-Meier method were used to analyze overall survival (OS) and progression-free survival (PFS).
Among the PDA patients, 101 patients underwent surgical treatment, 4 patients converted from LPD to OPD, and 7 of them received conservative treatment. Forty-six patients were cured of LPD, and 1 of them died shortly after the operation. Moreover, 44 patients received OPD, and there were 2 postoperative deaths. There were significant differences in the location of the operation time, duration of anesthesia, postoperative hemorrhage, abdominal infections, and postoperative pneumonia between the two groups (all p < 0.05). Multivariate analysis showed that LPD was an independent factor negatively correlated with the incidence of pneumonia (relative risk (RR) = 0.072, 95%CI: 0.016-0.326, p = 0.001) and abdominal infection (RR = 0.182, 95%CI: 0.047-0.709, p = 0.014). Also, there were no differences in OS (hazard ratio (HR) = 1.46, 95%CI: 0.60-3.53, p = 0.40) and PFS (HR = 1.46, 95%CI: 0.64-3.32, p = 0.37) at 12 months between the two groups.
LPD could be efficacy and feasible for managing selected PDA patients. Also, LPD has a better effect in reducing postoperative pneumonia and abdominal infection compared to OPD.
尽管腹腔镜胰十二指肠切除术(LPD)已被全球接受,用于治疗胰腺导管腺癌(PDA),但它是一项非常技术性和具有挑战性的手术。此外,尚不清楚 LPD 是否优于开放胰十二指肠切除术(OPD)。本研究总结了我们医学中心 LPD 治疗 PDA 的经验和疗效。
本回顾性队列研究纳入了 2019 年 10 月至 2021 年 1 月在江南大学附属医院就诊的 PDA 患者。患者接受 LPD 或 OPD 治疗。比较手术时间、麻醉持续时间、术中出血量、术后并发症和短期结果。Cox 比例风险模型和 Kaplan-Meier 法用于分析总生存期(OS)和无进展生存期(PFS)。
在 PDA 患者中,101 例患者接受了手术治疗,4 例患者从 LPD 转为 OPD,7 例患者接受了保守治疗。46 例患者接受了 LPD 治愈,其中 1 例术后不久死亡。此外,44 例患者接受了 OPD 治疗,有 2 例术后死亡。两组手术时间、麻醉持续时间、术后出血、腹部感染和术后肺炎的部位存在显著差异(均 p < 0.05)。多因素分析显示,LPD 是肺炎(相对危险度(RR)=0.072,95%CI:0.016-0.326,p=0.001)和腹部感染(RR=0.182,95%CI:0.047-0.709,p=0.014)发生率的独立负相关因素。此外,两组患者 12 个月的 OS(风险比(HR)=1.46,95%CI:0.60-3.53,p=0.40)和 PFS(HR=1.46,95%CI:0.64-3.32,p=0.37)无差异。
LPD 可有效治疗选定的 PDA 患者,且具有可行性。此外,与 OPD 相比,LPD 在降低术后肺炎和腹部感染方面效果更好。